Altimmune Balance Sheet Health

Financial Health criteria checks 6/6

Altimmune has a total shareholder equity of $133.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $147.9M and $14.5M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$139.38m
EquityUS$133.38m
Total liabilitiesUS$14.49m
Total assetsUS$147.86m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 3G0's short term assets ($145.8M) exceed its short term liabilities ($8.6M).

Long Term Liabilities: 3G0's short term assets ($145.8M) exceed its long term liabilities ($5.8M).


Debt to Equity History and Analysis

Debt Level: 3G0 is debt free.

Reducing Debt: 3G0 has no debt compared to 5 years ago when its debt to equity ratio was 0.2%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 3G0 has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: 3G0 has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 28.3% each year.


Discover healthy companies